208 related articles for article (PubMed ID: 33061966)
1. Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis.
Li SY; Zhao YL; Yang YF; Wang X; Nie M; Wu XY; Mao JF
Int J Endocrinol; 2020; 2020():4732021. PubMed ID: 33061966
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis.
Kim SH; Park JJ; Kim KH; Yang HJ; Kim DS; Lee CH; Jeon YS; Shim SR; Kim JH
Int Urol Nephrol; 2021 Sep; 53(9):1733-1746. PubMed ID: 34089171
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
Cai X; Tian Y; Wu T; Cao CX; Li H; Wang KJ
Asian J Androl; 2014; 16(1):146-52. PubMed ID: 24369149
[TBL] [Abstract][Full Text] [Related]
4. Testosterone and metabolic syndrome: a meta-analysis study.
Corona G; Monami M; Rastrelli G; Aversa A; Tishova Y; Saad F; Lenzi A; Forti G; Mannucci E; Maggi M
J Sex Med; 2011 Jan; 8(1):272-83. PubMed ID: 20807333
[TBL] [Abstract][Full Text] [Related]
5. [Testosterone replacement therapy improves metabolic indexes of the patients with hypogonadism: A meta-analysis].
Wang W; Wu J; Fan YF; Yang ZP; Zhu W; Yang GT; He JB
Zhonghua Nan Ke Xue; 2022 Oct; 28(10):926-934. PubMed ID: 37838960
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
7. An updated systematic review and meta-analysis of the effects of testosterone replacement therapy on erectile function and prostate.
Xu Z; Chen X; Zhou H; Ren C; Wang Q; Pan Y; Liu L; Liu X
Front Endocrinol (Lausanne); 2024; 15():1335146. PubMed ID: 38344665
[TBL] [Abstract][Full Text] [Related]
8. Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials.
Yu X; Wei Z; Liu Y; Zhang X; Wang Q
Sex Med; 2021 Aug; 9(4):100403. PubMed ID: 34298329
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes mellitus and testosterone: a meta-analysis study.
Corona G; Monami M; Rastrelli G; Aversa A; Sforza A; Lenzi A; Forti G; Mannucci E; Maggi M
Int J Androl; 2011 Dec; 34(6 Pt 1):528-40. PubMed ID: 20969599
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Testosterone Therapy in Type 2 Diabetic Hypogonadal Adult Males: A Systematic Review and Meta-Analysis.
Kumari K; Kumar R; Memon A; Kumari B; Tehrim M; Kumari P; Shehryar M; Islam H; Islam R; Khatri M; Kumar S; Kumar A
Clin Pract; 2023 Mar; 13(2):454-469. PubMed ID: 36961066
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone replacement treatment in testosterone deficiency syndrome patients with metabolic syndrome.
Jeong SM; Ham BK; Park MG; Oh MM; Yoon DK; Kim JJ; Moon du G
Korean J Urol; 2011 Aug; 52(8):566-71. PubMed ID: 21927705
[TBL] [Abstract][Full Text] [Related]
12. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
Khripun I; Vorobyev S; Belousov I; Kogan M; Zitzmann M
Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
[TBL] [Abstract][Full Text] [Related]
13. Testosterone Therapy: What We Have Learned From Trials.
Corona G; Torres LO; Maggi M
J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
[TBL] [Abstract][Full Text] [Related]
14. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
16. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Yassin DJ; Doros G; Hammerer PG; Yassin AA
J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
[TBL] [Abstract][Full Text] [Related]
17. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).
Jones TH; Arver S; Behre HM; Buvat J; Meuleman E; Moncada I; Morales AM; Volterrani M; Yellowlees A; Howell JD; Channer KS;
Diabetes Care; 2011 Apr; 34(4):828-37. PubMed ID: 21386088
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement.
Sonmez A; Haymana C; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
Endocr J; 2015; 62(7):605-13. PubMed ID: 25924666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]